Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03818061 2023-09-28

ATHENA

Phase 2 Unknown

33 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00409565 2017-10-20

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

48 enrolled 14 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00423930 2017-08-18

Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2 Completed

44 enrolled 9 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00703976 2017-04-04

Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

Phase 2 Completed

80 enrolled 7 charts

Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT00968435 2016-08-10

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00281840 2015-06-09

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2 Completed

30 enrolled 9 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00203905 2014-01-17

A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck

Phase 2 Completed

23 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01262859 2014-01-13

Pilot Study for Locally Advanced Head and Neck Cancer

Phase 2 Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT00392704 2013-02-22

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Phase 2 Completed

60 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

Clinical Trials

Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

ATHENA

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck

Pilot Study for Locally Advanced Head and Neck Cancer

Treatment of Head & Neck Cancer With Chemotherapy and Radiation